Edwards Lifesciences warns on burst balloon risk with Sapien 3 Ultra heart valve

July 18, 2019 By Brad Perriello Leave a Comment

Edwards Lifesciences (NYSE:EW) warned doctors about the low risk of burst balloons during implantation of its Sapien 3 Ultra replacement heart valve, cautioning physicians to closely follow the instructions for use to avoid the problem.

The Irvine, Calif.-based medical device maker’s latest iteration of its transcatheter aortic valve replacement won CE Mark approval in the European Union in November 2018; FDA approval followed in December of that year.

In an undated field advisory, Edwards said it received an unspecified number of reports of burst balloons with the Sapien 3 Ultra “which have resulted in significant difficulty retrieving the Sapien 3 Ultra delivery system into the sheath and withdrawing the system from the patient.”

Edwards said the the complaint rate for balloon burst is about 1.0% “based on the limited experience with the device. Of those reports, approximately 0.5% resulted in clinical implications for the patient, the company said, including difficulty removing the valve’s delivery system, vascular injury, bleeding and/or the need for surgical intervention.

“Valve deployment was successful in these cases. Following investigations into these events, Edwards has not identified any evidence of devices that did not conform to specifications,” the company said.

Its investigation turned up two factors influencing balloon bursts, excess inflation volume and fast inflation conditions, both of which are addressed in the Sapien 3 Ultra instructions for use. The TAVR device’s balloon is designed for slow and continuous inflation and a three-second hold once fully inflated, with prescribed volumes for valve deployment.

An additional warning is slated to be added to the device’s IFU, the company said, cautioning that failure to slowly inflate to the prescribed volumes “may result in balloon rupture, difficulty retrieving the delivery system, and may require subsequent conversion to surgical intervention,” Edwards said in the letter.

“Further investigation has also identified a new method for retrieving a burst Sapien 3 Ultra balloon through the sheath. It should be noted that this technique may not resolve all retrieval scenarios,” the company said, noting that it’s updating its training materials to include the method.

DeviceTalks Weekly Podcast: Deconstructing medtech’s alphabet soup – DPA, MDR, FDA are all in the news
In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry. Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than… […]
AdvaMed: Invoking Defense Production Act could hinder U.S. medtech imports
Forcing manufacturers to repurpose their production lines to make equipment to fight the coronavirus epidemic might actually hurt the U.S. supply of those items, the head of medtech trade group AdvaMed said today. AdvaMed officials have talked with U.S. secretary of Health and Human Services Alex Azar and FDA commissioner Dr. Stephen Hahn about medtech… […]
March 2020 Issue: Is software key to medical 3D printing innovation?
What’s the word on ethylene oxide? The coronavirus pandemic has pushed a lot of news out of people’s minds, but medtech has other big issues to deal with. For instance, 8 months have passed since the FDA issued a public challenge for alternatives to ethylene oxide (EtO) as a sterilant for medical devices. As I… […]
GE Healthcare quadruples ventilator production at Wisconsin plant
General Electric Healthcare (NYSE:GE) this week announced that it is doubling its production capacity for ventilators and expanding its Madison, Wisconsin, production line to 24-hour operation. In a report on GE’s website, the company shared that it has doubled its capacity of ventilator production with plans to double it again by the end of the second… […]
FDA issues FAQ on 3D-printed equipment against coronavirus
Intrepid 3D printing companies and individuals who want to print masks, gowns and other personal protective equipment (PPE) to fight the coronavirus pandemic might want to take a look at the FDA’s new frequently asked questions page on the topic. While it says it welcomes coronavirus-fighting efforts, the agency said that 3D-printed masks are unlikely… […]
Software is enabling medical 3D printing innovation: Here’s how
The 3D printers themselves get a lot of attention, but for 3D-printing to become ubiquitous in the medtech space, software will have to play a key role. A 3D printer without software to tell it where to place the material is a really nice, expensive coffee table, according to Scott Rader, a former Stratasys GM… […]
This open source ventilator hackathon could help fight the coronavirus
Infineon engineers developed a 3D printed lung ventilator to help address the shortage of ventilators due to the COVID-19 pandemic. The German federal government held a hackathon called #WirvsVirus (“We against the virus”) where 42,000 people met to find solutions to challenges from the coronavirus. Infineon engineers, led by Mahmoud Ismail who has a doctorate… […]
Could these DIY ventilators stop coronavirus from killing people?
Amid the global crisis caused by the coronavirus pandemic, hospitals and healthcare facilities are reporting shortages of vital equipment that not only keeps the patients safe, but the staffers, too. One important device for which demand has ramped up is ventilators for patients who need assistance with their breathing due to the respiratory effects of… […]
DIY ventilators? Not unless there’s a zombie apocalypse.
News reports of the COVID-19 virus have given a lot of space to the shortage of respiratory ventilators. The Society of Critical Care Medicine claims at least 950,000 U.S. patients could need ventilators but hospitals only have 160,000. One response to statistics like these has been a movement among open-source promoters to initiate community-designed ventilators… […]
FDA announces EUAs related to ventilators to treat coronavirus
Amid a shortage of ventilators for treating coronavirus, the FDA put out a statement confirming its stance on issuing emergency use authorizations for potential temporary fixes. The FDA said it is operating on the basis of a EUA determination that the U.S. Dept. of Health and Human Services issues on Feb. 4. Earlier this week, HHS declared… […]
Hack the Crisis: Life-saving pneumatics from Emerson’s ASCO and Aventics
As the United States continues to focus on social distancing to combat COVID-19, more companies are revealing how the move home for their workers is impacting their business. Despite this, companies like Emerson’s ASCO and Aventics divisions continue to step up production on key technologies used in life sciences and laboratories, including ventilators, respirators, hospital… […]